$17M sweet spot round size
Most of their 167 investments are in rounds between $10M and $32M
1980
ERS electronic GmbH raised undisclosed on June 1, 2023
Investors: Gimv
Complement Therapeutics raised $79M on April 17, 2023
Investors: Hadean Ventures, Forbion, PANAKES, BGV (BioGeneration Ventures), Cambridge Innovation Capital plc, Seroba-Kernel Ltd (Ireland) and Gimv
Mediar Therapeutics raised $85M on March 15, 2023
Investors: Pureos Bioventures, Mission BioCapital, Bristol-Myers Squibb, UK, Sofinnova Partners and Gimv
FIRE1 Foundry raised $25M on March 15, 2023
Investors: Novo Holdings, Gilde Healthcare, Andera Partners, Lightstone Ventures, National Treasury Management Agency and Gimv
Paleo raised $13M on February 21, 2023
Investors: SFPI-FPIM, Planet A Ventures, DSM Venturing, Siddhi Capital, Beyond Impact VC and Gimv
JenaValve Technology, Inc. raised $100M on August 31, 2022
Investors: 沛嘉医疗科技(苏州) 有限公司, Qatar Investment Authority, -, Innovatus Capital Partners and Gimv
Imcheck Therapeutics raised $100M on June 13, 2022
Investors: Pureos Bioventures, The Invus Group, Earlybird Venture Capital, Eurazeo, The Leukemia & Lymphoma Society, Wellington Partners, EQT Life Sciences and Gimv
ImmunOs Therapeutics AG raised $73M on June 7, 2022
Investors: GL Capital Group, PEAK6, Samsara BioCapital, Mission BioCapital, Redalpine, Lightspeed Venture Partners and Gimv
BioConnection B.V. raised undisclosed on April 22, 2022
Investors: Mibiton Foundation and Gimv
Precirix raised $88M on March 16, 2022
Investors: Pontifax Venture Capital, Inkef, HealthCap, Novo Holdings, V-Bio Ventures, BioMedPartners, Forbion and Gimv